These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36424030)

  • 1. Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases.
    Weisman MH
    Rheum Dis Clin North Am; 2023 Feb; 49(1):xiii-xiv. PubMed ID: 36424030
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases.
    Karpouzas GA; Husni ME
    Rheum Dis Clin North Am; 2023 Feb; 49(1):xv-xvi. PubMed ID: 36424031
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we be morbid about comorbidities in the rheumatic diseases?
    Elewaut D; Goodson N; Fleischmann R
    Rheumatology (Oxford); 2013 Jan; 52(1):1-2. PubMed ID: 23238977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of comorbidities in patients suffering from inflammatory rheumatic diseases].
    Alexe R; Benillouche E; Dan D
    Rev Med Suisse; 2022 Mar; 18(773):471-476. PubMed ID: 35306767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular manifestations and comorbidities in rheumatic diseases: perspectives on timely diagnosis, prevention, and treatment.
    Gasparyan AY
    Clin Rheumatol; 2023 Oct; 42(10):2531-2533. PubMed ID: 37698746
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignancy as a comorbidity in rheumatic diseases.
    Turesson C; Matteson EL
    Rheumatology (Oxford); 2013 Jan; 52(1):5-14. PubMed ID: 22829694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative.
    Baillet A; Gossec L; Carmona L; Wit Md; van Eijk-Hustings Y; Bertheussen H; Alison K; Toft M; Kouloumas M; Ferreira RJ; Oliver S; Rubbert-Roth A; van Assen S; Dixon WG; Finckh A; Zink A; Kremer J; Kvien TK; Nurmohamed M; van der Heijde D; Dougados M
    Ann Rheum Dis; 2016 Jun; 75(6):965-73. PubMed ID: 26984008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?
    Del Rincón I
    Arthritis Rheum; 2009 Oct; 61(10):1284-6. PubMed ID: 19790116
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing comorbidities in the rheumatic diseases: the new reality.
    Wang BW
    J Rheumatol; 2003 May; 30(5):899-901. PubMed ID: 12734877
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals.
    van der Burg LR; Boonen A; van Amelsvoort LG; Jansen NW; Landewé RB; Kant I
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):157-63. PubMed ID: 23926070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities in inflammatory joint and spine diseases in XXI century.
    Gaydukova IZ; Akulova AI; Rebrov AP
    Ter Arkh; 2018 Dec; 90(12):90-95. PubMed ID: 30701839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Morbidity and Mortality Among Working Individuals With Rheumatic Disease: Results From a Large Prospective Cohort Study.
    van der Burg LR; van Amelsvoort LG; Boonen A; Jansen N; Kant IJ; Landewé RB
    J Clin Rheumatol; 2015 Oct; 21(7):359-63. PubMed ID: 26398463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.
    Braun J; Krüger K; Manger B; Schneider M; Specker C; Trappe HJ
    Dtsch Arztebl Int; 2017 Mar; 114(12):197-203. PubMed ID: 28407841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Østergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Nørgaard Agerbo J; Ziegler C; Lund Hetland M
    RMD Open; 2021 May; 7(2):. PubMed ID: 33941664
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular comorbidity in rheumatic diseases.
    Nurmohamed MT; Heslinga M; Kitas GD
    Nat Rev Rheumatol; 2015 Dec; 11(12):693-704. PubMed ID: 26282082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular mortality in patients with inflammatory rheumatic disorders.
    Allanore Y
    Joint Bone Spine; 2007 Mar; 74(2):120-2. PubMed ID: 17324603
    [No Abstract]   [Full Text] [Related]  

  • 18. Adding to complexity: comorbidity in paediatric rheumatic disease.
    Smith EM; Foster HE; Beresford MW
    Rheumatology (Oxford); 2013 Jan; 52(1):22-33. PubMed ID: 23024018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of Nocardia infection in patients with rheumatic diseases.
    Yamagata M; Hirose K; Ikeda K; Nakajima H
    Clin Dev Immunol; 2013; 2013():818654. PubMed ID: 24171035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling comorbidity associated with rheumatic diseases in standard practice.
    Palmer D; El Miedany Y
    Br J Nurs; 2017 Apr; 26(7):380-387. PubMed ID: 28410044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.